February 4, 2017
View Full PaperH1‐antihistamine‐refractory chronic spontaneous urticaria: it's worse than we thought – first results of the multicenter real‐life AWARE study
Key Points
Key points are not available for this paper at this time.
Abstract
This study reveals that German H1-antihistamine-refractory CSU patients have high rates of uncontrolled disease, angioedema, and comorbid CIndU, are undertreated, have impaired QoL, and rely heavily on healthcare resources.
Cite This Study
Maurer et al. (Sat,) studied this question.